NAMSA
↗Northwood, Ohio, USA
NAMSA is the world's leading MedTech-focused Contract Research Organization (CRO) and consulting firm. Founded in 1967, it provides a full continuum of development solutions, including laboratory testing, clinical research, and regulatory, quality, and reimbursement consulting for medical device and in vitro diagnostic (IVD) manufacturers.
The company is recognized for its 'MRO' (Medical Research Organization) approach, integrating scientific expertise with regulatory strategy to accelerate time-to-market for innovative medical technologies. Under the ownership of ArchiMed, NAMSA has aggressively expanded its global footprint through a series of strategic acquisitions, positioning itself as a dominant player in the global MedTech outsourcing market.
CLASSIFICATION
SIZE & FINANCIALS
Employees:1001-5000
Revenue:$250M-$500M
Founded:1967
Ownership:private
Status:operating
FUNDING
Stage:Private Equity-Backed
Total Raised:$133M+
Investors:ArchiMed, Ares Management, Omnes Capital, IdiCo
PIPELINE
Stage:Commercial
Lead Drug Stage:N/A (Service Provider)
Modalities:Medical Devices, IVDs, SaMD (Software as a Medical Device), Combination Products
Active Trials:500
Trial Phases:Phase 1: 150 | Phase 2: 200 | Phase 3: 100 | Phase 4: 50
FDA Approvals:0
EMA Approvals:0
CORPORATE STRUCTURE
Parent Company:ArchiMed
Acquired By:ArchiMed (Majority Stake) (2020-09-01)
Subsidiaries:Clin-Tech Ltd, Perfectus Biomed Group, SUAZIO, American Preclinical Services (APS), CRI - Clinical Research Institute
Key Partnerships:Terumo, LimFlow, Endonovo Therapeutics
COMPETITION
Position:Leader
Competitors:IQVIA (MedTech Division), ICON plc, Syneos Health, RQM+, WuXi AppTec (Global), Charles River Laboratories
LEADERSHIP
Key Executives:
Brian P. Smith - CEO
Michael Brookman - CFO
Dr. Marija Buchholz - EVP, Global Clinical and Consulting Services
Scientific Founders:The Gorski Family
Board Members:André-Michel Ballester (ArchiMed), Brian P. Smith
LINKS
Disclaimer: IntuitionLabs.ai is not affiliated with, endorsed by, or associated with NAMSA. The information on this page was collected and compiled using AI agents from publicly available sources. While we strive for accuracy, this data may be incomplete, outdated, or contain errors. For official information, please visit the company's website directly. If you notice any inaccurate information, please contact us.